CooperVision Lens Care Limited v The Commissioners for HMRC
Decision date: 2 March 2026
Neutral citation: [2026] UKFTT 324 (TC)
Overall AI summary confidence: medium
Short overview
This short overview is intended to summarise the case, issues and outcome so far as they are supported by the judgment.
AI confidence in this short overview: medium
This appeal concerned whether certain historic share acquisitions were "employment-related securities" for PAYE/NICs purposes, whether the consideration received on the 2014 sale exceeded market value, and whether HMRC’s regulation 80 PAYE determination was within time. The First, Second and Third Shares were held to be employment-related securities and the tribunal found the purchaser’s global price should be treated as market value (allocating pro rata), so HMRC’s PAYE/NICs determination was valid within the six‑year careless‑discovery period. The only successful limb for the appellant was that the Fourth Shares were not employment‑related securities.
Ratio decidendi
This summary is intended to identify the ratio decidendi, meaning the legal reasons for deciding and the binding part of the decision.
AI confidence in this ratio decidendi summary: medium
The tribunal’s operative reasoning supports two propositions it treated as binding for this case: (1) replacement securities or converted rights that reflect earlier option rights granted "by reason of" employment can qualify as employment‑related securities under s 421B ITEPA; and (2) where a purchaser buys the entire share capital and the allocation of the purchaser’s single global price among vendors arises from private negotiation rather than an open‑market willing‑buyer/willing‑seller process, the purchaser’s global price allocated pro rata may be treated as the relevant market value for those shares.
Obiter dicta
This summary is intended to identify obiter dicta, meaning observations made by the way that were not necessary to deciding the case and are not binding.
AI confidence in this obiter dicta summary: medium
The tribunal observed (non‑decisively) that valuation standards and expert evidence (e.g. IVS, IPEV) can inform but do not displace the statutory market‑value inquiry focused on the rights attaching to the shares as acquired, and that deal drafting and allocation mechanics put forward by advisers should be treated with caution when assessing whether allocations reflect true market value.
Warning
This chunk is very long and contains dense, contested factual and expert material; some witness evidence is found unreliable and portions of the factual record are acknowledged to be limited or speculative. The notes are dense and contain contested factual findings and reliability assessments of witnesses; they appear materially complex and somewhat noisy.